Remove tag insulin
article thumbnail

FDA Enables Generic Insulins with Lower Prices

Insulin Nation

While COVID-19 has distracted our attention from affordable insulin to focus on social distancing and hoarding toilet paper, the U.S. Food & Drug Administration is finally making a serious effort to improve our access to insulin. . Why no Generic Insulins? A long-standing issue with insulin is the lack of a “generic.”

article thumbnail

For older adults, the future of wearables is predictive

Aging in Place Technology Watch

Diabetes insulin monitoring/dosing patches are in the marke t. Today’s view includes fall risk, cardiac irregularities, insulin requirements, possible stroke, behavior, mood, sleep, or medication reaction. category tags: wearables, smart watch , Technology - AARP. More when there’s more.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Acronyms and References

Insulin Nation

Automated insulin delivery. insulin carb ratio. Insulin on board. NPH (intermediate insulin). Regular insulin. Basal Insulin Management in T1D. Bolus Insulin Management in T1D. Using CGMs, Insulin Pens, and Pumps. The post Acronyms and References appeared first on Insulin Nation.

40
article thumbnail

FDA Approves Fast-Acting Fiasp Insulin

Insulin Nation

Novo Nordisk announced on September 29th, 2017 that it has received FDA market approval for its new fast-acting insulin, Fiasp*. This was the second attempt by Novo Nordisk to gain the FDA’s approval for the long-anticipated fast-acting insulin. Fiasp is being touted as a faster-acting fast-acting insulin.

62
article thumbnail

Food Effect on Glucose

Insulin Nation

Insulin absorption was modeled as early as 1959, and compartment models for it followed. Insulin’s effect on glucose was modeled with compartment to compartment flows as well. This incorporated both production in Type 2 patients and disposal, including how it was potentially diminished by insulin resistance. Experimental setup.

46
article thumbnail

Five Quick-Takes from the ADA 77th Scientific Sessions

Insulin Nation

Add-ons to insulin are going to be a thing for Type 1 diabetes. Pharmaceutical companies are coming to terms with the limits and costs of designing better insulin, and generic or biosimilar insulins are entering the marketplace. Insulin Nation (@InsulinNation) June 10, 2017. The pitchforks were out. Zero f s given.

article thumbnail

Sampling technology for managing diabetes

Aging in Place Technology Watch

category tags: mHealth-Digital Health-Telehealth-Voice Health.

mHealth 96